Twice-Daily Dosing of Loracarbef 200 mg Versus 400 mg in the Treatment of Patients with Acute Maxillary Sinusitis

Autor:	Zeckel, M. L. et al.
Zdroj:	Clinical Therapeutics; 1995, Vol. 17 Issue: 2 p214-214, 1p
Databáze:	Supplemental Index
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect